v3.25.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Retained Earnings
Adjustment
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Adjustment
Total
Balance at Mar. 31, 2022 $ 221 $ 62,048   $ 104,931 $ (9,951)   $ 157,249
Balance (in shares) at Mar. 31, 2022 22,127,396            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       18,069     18,069
Cash dividend on common stock       (5,174)     (5,174)
Exercise of stock options   4         $ 4
Exercise of stock options (in shares) 1,511           1,511
Common stock repurchased $ (9) (6,697)         $ (6,706)
Common stock repurchased (in shares) (975,666)            
Restricted stock grants and forfeited, net (in shares) 68,719            
Stock-based compensation expense   390         390
Purchase of subsidiary shares from non-controlling interest   (234)         (234)
Other comprehensive income (loss), net         (8,359)   (8,359)
Balance at Mar. 31, 2023 $ 212 55,511 $ (53) 117,826 (18,310) $ (53) 155,239
Balance (in shares) at Mar. 31, 2023 21,221,960            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       3,799     3,799
Cash dividend on common stock       (5,073)     (5,073)
Exercise of stock options   36         $ 36
Exercise of stock options (in shares) 12,799           12,799
Common stock repurchased $ (1) (576)         $ (577)
Common stock repurchased (in shares) (109,162)            
Restricted stock grants and forfeited, net (in shares) (14,554)            
Stock-based compensation expense   34         34
Other comprehensive income (loss), net         2,183   2,183
Balance at Mar. 31, 2024 $ 211 55,005   116,499 (16,127)   155,588
Balance (in shares) at Mar. 31, 2024 21,111,043            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income       4,903     4,903
Cash dividend on common stock       (1,685)     (1,685)
Common stock repurchased $ (3) (1,997)         (2,000)
Common stock repurchased (in shares) (358,631)            
Restricted stock grants and forfeited, net (in shares) 223,788            
Stock-based compensation expense   384         384
Other comprehensive income (loss), net         2,824   2,824
Balance at Mar. 31, 2025 $ 208 $ 53,392   $ 119,717 $ (13,303)   $ 160,014
Balance (in shares) at Mar. 31, 2025 20,976,200